Correlation Between Pacira BioSciences, and Oric Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Pacira BioSciences, and Oric Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pacira BioSciences, and Oric Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pacira BioSciences, and Oric Pharmaceuticals, you can compare the effects of market volatilities on Pacira BioSciences, and Oric Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pacira BioSciences, with a short position of Oric Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pacira BioSciences, and Oric Pharmaceuticals.

Diversification Opportunities for Pacira BioSciences, and Oric Pharmaceuticals

-0.57

Correlation Coefficient

Pacira BioSciences,  Oric Pharmaceuticals

Excellent diversification

The 3 months correlation between Pacira and Oric is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Pacira BioSciences, and Oric Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oric Pharmaceuticals and Pacira BioSciences, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pacira BioSciences, are associated (or correlated) with Oric Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oric Pharmaceuticals has no effect on the direction of Pacira BioSciences, i.e., Pacira BioSciences, and Oric Pharmaceuticals go up and down completely randomly.

Pair Corralation between Pacira BioSciences, and Oric Pharmaceuticals

Given the investment horizon of 90 days Pacira BioSciences, is expected to under-perform the Oric Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Pacira BioSciences, is 1.33 times less risky than Oric Pharmaceuticals. The stock trades about -0.02 of its potential returns per unit of risk. The Oric Pharmaceuticals is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  562.00  in Oric Pharmaceuticals on September 29, 2024 and sell it today you would earn a total of  263.00  from holding Oric Pharmaceuticals or generate 46.8% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Pacira BioSciences,  vs.  Oric Pharmaceuticals

Pacira BioSciences,

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Pacira BioSciences, are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Pacira BioSciences, showed solid returns over the last few months and may actually be approaching a breakup point.

Oric Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Oric Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's forward indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Pacira BioSciences, and Oric Pharmaceuticals

The main advantage of trading using opposite Pacira BioSciences, and Oric Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pacira BioSciences, position performs unexpectedly, Oric Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oric Pharmaceuticals will offset losses from the drop in Oric Pharmaceuticals' long position.

The idea behind Pacira BioSciences, and Oric Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.